Cascade Prodrug Inc. and Uneedle are advancing their collaboration to evaluate CPD100, Cascade’s first-in-class hypoxia-targeted therapeutic, in neovascular, or wet, age-related macular degeneration.

This bill requires school districts to adopt policies to ensure students do not use their cell phones during class time in a ...

Celldetective is an open-source software integrating segmentation, tracking, and event detection to perform high-throughput end-to-end study of dynamic cell interactions, without requiring coding ...

The new BMW X5 is not arriving as a simple luxury SUV refresh. It is arriving as BMW’s rolling answer to an industry that no ...

A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.

Should a property owner be allowed to build a cell tower if it meets city requirements, even if nearby residents object? That ...

To help cure Alzheimer's disease and other types of dementia, we need to understand the mechanisms through which it damages ...

When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...

Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...

Objective Recent advances in giant cell arteritis (GCA) management aim to reduce glucocorticoid (GC). We described changes in ...

Intermountain Health is expanding an innovative and high-level cancer treatment patients at more hospitals across Utah, ...